Abstract
Background and purpose
Non‐myelopathic degenerative cervical spinal cord compression (NMDC) frequently occurs throughout aging and may progress to potentially irreversible degenerative cervical myelopathy (DCM). Whereas standard clinical magnetic resonance imaging (MRI) and electrophysiological measures assess compression severity and neurological dysfunction, respectively, underlying microstructural deficits still have to be established in NMDC and DCM patients. The study aims to establish tract‐specific diffusion MRI markers of electrophysiological deficits to predict the progression of asymptomatic NMDC to symptomatic DCM.
Methods
High‐resolution 3 T diffusion MRI was acquired for 103 NMDC and 21 DCM patients compared to 60 healthy controls to reveal diffusion alterations and relationships between tract‐specific diffusion metrics and corresponding electrophysiological measures and compression severity. Relationship between the degree of DCM disability, assessed by the modified Japanese Orthopaedic Association scale, and tract‐specific microstructural changes in DCM patients was also explored.
Results
The study identified diffusion‐derived abnormalities in the gray matter, dorsal and lateral tracts congruent with trans‐synaptic degeneration and demyelination in chronic degenerative spinal cord compression with more profound alterations in DCM than NMDC. Diffusion metrics were affected in the C3‐6 area as well as above the compression level at C3 with more profound rostral deficits in DCM than NMDC. Alterations in lateral motor and dorsal sensory tracts correlated with motor and sensory evoked potentials, respectively, whereas electromyography outcomes corresponded with gray matter microstructure. DCM disability corresponded with microstructure alteration in lateral columns.
Conclusions
Outcomes imply the necessity of high‐resolution tract‐specific diffusion MRI for monitoring degenerative spinal pathology in longitudinal studies.
Keywords: diffusion magnetic resonance imaging, diffusion tensor imaging, spinal cord compression
Tract‐specific diffusion magnetic resonance imaging revealed microstructural changes in non‐myelopathic and myelopathic degenerative spinal cord compression compared to healthy controls. Alterations were found in dorsal and lateral columns as well as gray matter and correlated with relevant electrophysiological abnormalities and clinical modified Japanese Orthopaedic Association scale.

INTRODUCTION
The relative resilience of the cervical spinal cord (CSC) to degenerative changes might delay the development of clinically manifest myelopathy and result in non‐myelopathic degenerative cervical spinal cord compression (NMDC) [1, 2]. The prevalence of NMDC progressively increases throughout aging affecting up to 40% of Caucasian individuals over 60 years of age [3, 4, 5]. Over time, a portion of NMDC patients progress into potentially irreversible degenerative cervical myelopathy (DCM) [2, 6], which is the most common non‐traumatic cause of CSC dysfunction. Delineation of risk factors of NMDC progression to the DCM remains an unsolved challenge [2, 6, 7]. Whilst radiological measures such as cross‐sectional area (CSA), anteroposterior diameter or compression ratio (CR) together with electrophysiological abnormalities might be useful in predicting DCM development [6], standard clinical magnetic resonance imaging (MRI) protocols fail to describe microstructural CSC abnormalities in NMDC and DCM. Hyperintensity on T2‐weighted scans, considered as a radiological correlate of myelopathy, is not inevitably observed even in the most severe DCM patients with clinical myelopathic signs [8]. Yet, it remains a critical factor influencing decision‐making in decompressive surgery [9]. Thus, quantitative MRI markers are urgently needed to detect early microstructural NMDC changes and predict progression into symptomatic DCM.
Whereas previous studies demonstrated the ability of diffusion MRI (dMRI) to depict profound microstructural CSC alteration in DCM patients [10, 11, 12, 13, 14, 15], NMDC reports provided inconclusive outcomes [6, 16, 17, 18]. However, all previous studies utilized single‐shell dMRI protocols that limited estimation of the high‐order diffusion models and exclusively quantified the diffusion tensor imaging (DTI) model [19]. Whereas DTI metrics are sensitive to microstructural integrity (i.e., fractional anisotropy [FA]) and axonal, myelin or membrane density deficits (i.e., axial [AD], radial [RD] and mean diffusivity [MD], respectively), the single tensor per voxel does not account for axonal, glial and extracellular compartments within the tissue and remains nonspecific [20]. To address this issue, optimized multi‐shell high angular resolution diffusion imaging (HARDI) sequence with reduced field of view, so‐called HARDI‐ZOOMit [21], were utilized to estimate critical microstructural information from single‐compartment DTI and the more advanced multi‐compartment ball‐and‐sticks model [22]. The ball‐and‐sticks model indeed better fits dMRI data than DTI [20] and more reliably captures the microstructural tissue property in each voxel.
High‐resolution multi‐shell diffusion and anatomical sequences were combined with state‐of‐the‐art postprocessing [23, 24, 25, 26] to achieve selective tract‐specific CSC analyses. Capability of the microstructural dMRI metrics to reliably reflect histopathological studies, which previously demonstrated tract‐specific distinctions in CSC integrity in degenerative compression [1, 27] was also investigated.
Thus, tract‐specific alterations in degenerative spinal cord compression at the compression level and also above the compression were hypothesized with more severe deficits in DCM patients than NMDC patients. Relationships between tract‐specific dMRI metrics and corresponding electrophysiology and compression severity, previously confirmed as risk factors of DCM development [6] were further hypothesized. Relationship between the degree of DCM disability assessed by the modified Japanese Orthopaedic Association (mJOA) scale [28] and tract‐specific diffusion‐informed microstructure was also explored.
MATERIALS AND METHODS
Participants
The ethical committee approved the study, and all participants signed an informed consent form. Healthy controls (HC) between 40 and 80 years of age had to be physically healthy with no history of any neurological or other somatic disorder. DCM and NMDC patients were recruited from the database of a spinal center of a tertiary university hospital. The requirements on subjects are shown in Figure 1a.
FIGURE 1.

Flowcharts of (a) participants’ requirements and (b) MRI data analysis
All subjects underwent a neurological examination to rule out DCM symptoms/signs in HC and NMDC individuals. The degree of DCM disability was assessed by an mJOA scale [28]. All participants underwent standard clinical MRI on a 1.5 T scanner to evaluate radiological signs of degenerative compression and estimate the maximal compression level (MCL), CSA and CR (see Supplementary Materials and Methods).
Non‐myelopathic degenerative cervical spinal cord compression patients and DCM patients underwent electrophysiological examination performed by experienced neurologists to detect abnormalities of dorsal columns and/or dorsal gray matter (GM) horns (i.e., somatosensory evoked potentials, SEP), dysfunction in lateral columns (i.e., motor evoked potentials, MEP) and lesions of ventral GM horns (i.e., electromyography, EMG) as described previously [2, 29]. Three DCM and 13 NMDC patients did not agree with electrophysiological examination. A detailed description of electrophysiological measures as well as the definition of MEP, SEP and EMG abnormalities is provided in the Supplementary Materials and Methods.
Magnetic resonance imaging acquisition
All participants were scanned on a 3 T Siemens Prisma scanner (Siemens Healthcare, Erlangen, Germany) using 64‐channel head/neck and 32‐channel spine coils. Lordosis, which could introduce a partial volume effect from the surrounding cerebrospinal fluid and negatively influence field homogeneity, was minimized by keeping the spinal cord as straight as possible. An optimized multi‐shell diffusion protocol with reduced field of view [21] with total acquisition time (TA) of 12 min, 46 s covering C3‐6 levels with 21 gradient waveform directions with b 1 = 550 s/mm2, 42 directions with b 2 = 1000 s/mm2 and seven b 0 images with anterior–posterior phase encoding, voxel size 0.65 × 0.65 × 3 mm3 after interpolation in Fourier space, original voxel size 1.30 × 1.30 × 3.00 mm3 was acquired. An additional five b 0 images with reversed posterior–anterior phase encoding were collected. All gradient waveforms were uniformly sampled over a q‐space sphere [30]. Axial T2*‐weighted MEDIC images with high grey/white matter contrast using interleaved acquisition (voxel size 0.35 × 0.35 × 2.5 mm3 after interpolation in Fourier space, original voxel size 0.70 × 0.70 × 2.5 mm3, TA ≈ 8 min) and T2‐weighted sagittal turbo spin‐echo images (voxel size 0.28 × 0.28 × 1.3 mm3 after interpolation in Fourier space, original voxel size 0.56 × 0.56 × 1.3 mm3, TA ≈ 9 min) were also collected. Detailed sequence parameters are listed in the Supplementary Materials and Methods.
Image analysis
Images were visually inspected by two independent observers to ensure data quality. Data were analyzed using the Spinal Cord Toolbox [26] v3.2.3 and FMRIB Software Library [31] v5.0.10 (Figure 1b). T2*‐w and T2‐w data were corrected for MR field induced intensity non‐uniformities using the N4 bias‐field correction tool, and interleaved T2*‐w axial data were additionally slice‐by‐slice corrected utilizing affine registration between even and odd slices followed by additive image fusion. Spinal cord segmentation and vertebral labeling of T2‐w sagittal data was performed and co‐registered with T2*‐w axial data. Then spinal cord segmentation using convolution neural network [23] of T2*‐w axial was performed and vertebral levels were defined [32] using initial information from T2‐w sagittal labeling. Finally, the T2*‐w spinal cord was registered to the PAM50 template [24] using C3 and C6 as labels. Diffusion data were corrected for motion, susceptibility and eddy current artifacts. A conventional DTI [19] model and a multi‐compartment ball‐and‐sticks [22] model were estimated to extract FA, MD, AD and RD as well as f 1 and d metrics. The PAM50 template was registered to diffusion data using the initial transformation from the T2*‐w axial image, and the probabilistic spinal cord atlas [25] was warped into diffusion data.
Metric extractions
Diffusion metrics were extracted per subject from all regions of interest (ROIs) utilizing the sct_extract_metric function [26] with use of the maximum a posteriori optimizing approach [25, 26] to eliminate partial volume effect and variability in tract size. ROIs included the GM, ventral, lateral, dorsal columns, fasciculus gracilis, fasciculus cuneatus, lateral corticospinal tracts, spinal lemniscus (i.e., spinothalamic and spinoreticular tracts), dorsal GM horns and ventral GM horns (Figure 2a). Diffusion metrics for individual ROIs were averaged from the whole C3‐6 area and from C3 above the compression vertebral level (Figure 2d).
FIGURE 2.

(a) Individual ROIs masks from probabilistic PAM50 atlas. (b) Lesion distribution caused by compressed anterior spinal artery. Filled areas are affected by the compression, that is, lateral columns, anterior part of dorsal columns and ventral GM horns. Adapted from Mair and Druckman [27]. (c) Individual ROIs related to electrophysiological measures: EMG, electromyography; SEP, somatosensory evoked potentials; MEP, motor evoked potentials. (d) Two analyzed areas, the C3‐6 area and C3 above the compression level. (e) Representative slices from the C4/5 disc from NMDC and DCM patients. From the left: T2*‐w axial image, CSC segmentation used for PAM50 registration, fractional anisotropy (FA) map, white matter columns, and gray matter (GM) and individual tracts registered into an FA map
Mean CSA at the C3 level was calculated to quantify atrophy above the compression level from high‐resolution T2*‐w data using the sct_process_segmentation function [26].
Statistical analysis
Statistical analysis was performed using Matlab R2019b (The Mathworks Inc.), Python 3.7 and SPSS 25 (IBM). Data normality was examined using the Shapiro–Wilk test. Comparison between groups in age, height, weight, body mass index (BMI) and CSA at C3 were tested by the Kruskal–Wallis H test, and sex by Fisher's exact test.
Between‐group differences in dMRI metrics from the C3‐6 area and above the compression (i.e., C3) level were analyzed per individual tract and column using ANCOVA with age and BMI as covariates using Tukey–Kramer post hoc tests. Analyses were corrected using the Holm–Bonferroni correction.
Associations between dMRI metrics from the C3‐6 area, age and BMI in 60 controls as well as between CSA and CR at MCL and dMRI metrics from the C3‐6 area and C3 above the compression level in DCM and NMDC together with the relationship between the degree of myelopathy (mJOA scale) and dMRI metrics at C3 in DCM were examined using the Spearman correlation. Relationships between electrophysiological abnormalities, reported as categorical and dMRI metrics, were quantified in NMDC and DCM patients by the Mann–Whitney rank tests with Holm–Bonferroni correction. MEPs were related to dMRI from motor tracts, that is, lateral columns and lateral corticospinal tracts. SEPs were correlated with sensory tracts, that is, the dorsal column, fasciculus cuneatus, fasciculus gracilis and dorsal GM horns. Relationships between EMG and dMRI from GM and ventral GM horns (Figure 2c) were examined. Finally, post hoc correlation analysis between quantitative electrophysiological parameters and dMRI metrics was performed (see the Supplementary Materials and Methods).
RESULTS
Participant characteristics
A total of 116 NMDC patients, 31 DCM patients and 64 HC were enrolled in the study. Ten DCM, 13 NMDC patients and four HC were initially excluded due to the presence of motion artifacts, low CSC/cerebrospinal fluid contrast in T2*‐w axial images preventing proper CSC segmentation, sub‐optimal fat saturation, and dMRI signal dropouts caused by excessive cardiac pulsatile motion.
The final group consisted of 103 NMDC patients, 21 DCM patients and 60 HC. Analyses did not reveal any statistically significant differences in age, height, weight, BMI or sex between groups (Table 1).
TABLE 1.
Characteristics of 184 participants
| Characteristic | Healthy controls (n = 60) | NMDC patients (n = 103) | DCM patients (n = 21) | p value |
|---|---|---|---|---|
| Age (years) | 53.7 ± 8.7 | 56.5 ± 9.8 | 58.2 ± 10.8 | 0.084 |
| Sex (females/males) | 38/22 | 59/44 | 12/9 | 0.711 |
| Height (cm) | 172.4 ± 9.8 | 170.0 ± 8.7 | 167.0 ± 10.5 | 0.227 |
| Weight (kg) | 78.9 ± 16.5 | 81.2 ± 16.7 | 81.7 ± 13.3 | 0.880 |
| Body mass index (BMI) | 26.5 ± 4.8 | 28.0 ± 4.6 | 28.8 ± 4.1 | 0.073 |
| Cross‐sectional area (CSA) at C3 level (mm2) | 69.7 ± 7.6 | 66.0 ± 7.4 | 56.7 ± 7.1 | <0.001* |
| mJOA | 18.0 ± 0.0 | 18 ± 0.0 | 14.5 ± 2.6 | |
| Maximally compressed level (MCL) | ||||
| C3/4 | – | 5 (4.8%) | 3 (14.3%) | |
| C4/5 | – | 28 (27.2%) | 4 (19.0%) | |
| C5/6 | – | 49 (47.6%) | 14 (66.7%) | |
| C6/7 | – | 21 (20.4%) | ‐ | |
| Compression ratio (CR) at MCL | – | 0.41 ± 0.07 | 0.35 ± 0.08 | |
| Cross‐sectional area (CSA) at MCL | – | 60.71 ± 11.3 | 52.14 ± 13.84 | |
| Number of stenotic levels | ||||
| 1 compression | – | 39 (37.9%) | 6 (28.6%) | |
| 2 compressions | – | 33 (32.0%) | 8 (38.1%) | |
| 3 compressions | – | 25 (24.3%) | 4 (19.0%) | |
| 4 compressions | – | 6 (5.8%) | 3 (14.3%) | |
| Electrophysiological measurements | ||||
| Abnormal MEP | – | 11 patients from 87 (12.6%) | 12 patients from 18 (66.7%) | |
| Abnormal SEP | – | 28 patients from 87 (32.2%) | 13 patients from 18 (72.2%) | |
| Abnormal EMG | – | 24 patients from 92 (26.1%) | 11 patients from 17 (64.7%) |
Asterisk (*) indicates significance (p < 0.05).
Abbreviations: DCM, degenerative cervical myelopathy; EMG, electromyography; MEP, motor evoked potentials; mJOA, modified Japanese Orthopaedic Association; NMDC, non‐myelopathic degenerative cervical spinal cord compression; SEP, somatosensory evoked potentials.
None of the 60 HC had MR signs of degenerative CSC compression, whilst all 103 NMDC and 21 DCM patients had MR signs of compression varying from focal impingement to flat compressions with partially preserved or lost subarachnoid space [2, 6]. The majority of patients (93.6%) had MCL at the C4/5 level and/or lower. Thus, level C3 was selected as a reference level above the compression to evaluate rostral microstructural changes.
Non‐myelopathic degenerative cervical spinal cord compression patients had no radiological signs or neurological symptoms/signs of DCM. Hyperintensities on T2‐w scans were found in one cervical level in 12 DCM patients and two cervical levels in two DCM patients. The mean mJOA scale in the DCM group was 14.5.
Five out of 21 DCM patients were excluded from C3‐6 analysis due to imperfect PAM50 atlas registration caused by severe compression, and these subjects were used only in the analysis of the C3 level. The accuracy of CSC segmentation and labeling was verified and corrected if necessary.
Detailed results for the relationship between dMRI metrics and compression measures are described in the Supplementary Results.
Cross‐sectional area at the C3 above the compression level
The Kruskal–Wallis H test detected a significant between‐group difference between groups in CSA above the compression level. Subsequent Dunn's post hoc tests showed significant (p FWEcorr < 0.05) CSA reduction between HCs and NMDC patients (−5.0%, p = 0.007), HCs and DCM patients (−18.4%, p < 0.0001) and NMDC and DCM (−14.1%, p < 0.0001) (Table 1, Figure S1).
Correlations between dMRI metrics and demographic characteristics
Analyses revealed significant decreases (p uncorr < 0.05) in f 1, FA, d and AD in the whole C3‐6 area with age, whilst the opposite relationship was found between RD and age in HC (Figure S2). FA, MD, AD and d showed significant negative correlations with BMI (Figure S3). Correlation outcomes proved age and BMI as confounding variables, which were thus included as covariates to test between‐group differences.
Distinctions between healthy controls and NMDC patients
Analysis of the C3‐6 area revealed significantly (p FWEcorr < 0.05) lower f 1 and FA in NMDC patients in dorsal and lateral tracts, that is, the fasciculus gracilis, lateral corticospinal tracts, spinal lemniscus and fasciculus cuneatus, compared to HC. Higher d, MD, AD and RD in NMDC patients relative to HC were observed in dorsal and lateral tracts and GM horns. Alterations in ventral columns were only revealed by the ball‐and‐sticks model, and NMDC patients showed higher d compared to HC.
Lower f 1 values at C3 above the compression level were found in lateral columns, specifically in spinal lemniscus, in NMDC patients in comparison to HCs (Figures 3 and 4, Table S1).
FIGURE 3.

Between‐group differences in diffusion metrics for tract‐specific ROIs from C3 above the compression level and C3‐6 area color coded by their p values (p FWEcor < 0.05)
FIGURE 4.

Violin plots showing between‐group differences from the C3‐6 area and C3 above the compression level. Markers indicate p FWEcorr < 0.05
Differences between healthy controls and DCM patients
Degenerative cervical myelopathy patients showed significantly lower f 1 and FA (p FWEcorr < 0.05) in dorsal and lateral tracts, that is, fasciculus cuneatus, fasciculus, lateral corticospinal tracts and spinal lemniscus, in the C3‐6 area compared to HC. The ball‐and‐sticks model demonstrated lower f 1 values in DCM patients relative to HC in ventral columns and ventral and dorsal GM horns. Higher MD and RD values in DCM patients in comparison to HC were detected in dorsal and lateral tracts, whilst higher RD in DCM patients was also observed in ventral columns. In contrast, higher d and AD in DCM patients were solely revealed in dorsal tracts. Ventral and dorsal GM horns exhibited higher d, MD, AD and RD in DCM patients compared to HC.
Lower f 1 in DCM patients relative to HC above the compression level was detected in dorsal and lateral tracts, that is, the fasciculus cuneatus, fasciculus, lateral corticospinal tracts, spinal lemniscus and dorsal GM horns, whilst lower FA affected identical areas but spared the dorsal GM. Higher MD and RD were found in dorsal and lateral columns and GM, higher d and AD were observed only in ventral GM horns and the GM of DCM patients compared to HCs. No changes were detected in dMRI metrics at the C3 level in ventral columns (Figures 3 and 4 and Table S1).
Comparisons between NMDC and DCM patients
Degenerative cervical myelopathy patients exhibited significantly lower f 1 and FA compared to NMDC patients in dorsal and lateral tracts, that is, the fasciculus cuneatus, fasciculus, lateral corticospinal tracts and spinal lemniscus, with lower f 1 values also in the dorsal GM horns of DCM patients at the C3‐6 level. Higher MD and RD were detected in the dorsal and lateral tracts as well as ventral and dorsal GM horns with higher d and AD in GM horns in DCM patients relative to NMDC patients.
Above the compression level, lower f 1 and FA and higher MD and RD were detected in the fasciculus cuneatus, fasciculus, lateral corticospinal tracts and spinal lemniscus, and the dorsal GM horns in DCM relative to NMDC. Higher d and AD were observed in GM, specifically in ventral GM horns in DCM compared to NMDC (Figures 3 and 4 and Table S1).
Relationship between dMRI and electrophysiological measures
Patients with abnormal MEP findings exhibited significantly lower f 1 and FA in lateral columns and lateral corticospinal tracts (p FWEcorr < 0.05) and lower AD in lateral columns compared to patients with normal MEP findings in the C3‐6 area. Similarly, patients with altered SEPs demonstrated significantly lower FA in the dorsal columns, fasciculus gracilis, fasciculus cuneatus and dorsal GM horns compared to unaffected patients. Abnormal EMG was also reflected by higher RD in GM and ventral GM horns comparing patients with abnormal and normal EMG (Figure 5 and Table S2).
FIGURE 5.

Violin plots showing relationship between electrophysiological finding and diffusion metrics extracted from the C3‐6 area and C3 above the compression level. Asterisks (*) indicate p FWEcorr < 0.05
A comparison of dMRI metrics at the C3 above the compression level revealed significantly lower f 1 and FA and higher RD in the lateral columns and lateral corticospinal tracts (p FWEcorr < 0.05) in patients with abnormal versus normal MEP. Also, lower d and AD were detected in the lateral columns in patients with abnormal MEP. Altered SEP measurements were associated with lower f 1 and FA in dorsal columns, fasciculus gracilis and fasciculus cuneatus, as well as lower FA and d in dorsal GM horns compared to patients with normal SEP. Lower f 1, FA and RD were detected in the GM in patients with abnormal EMG compared to individuals with unaffected EMG (Figure 5 and Table S2).
Overall, patients with abnormal electrophysiological measurements showed significantly lower f 1, FA, d and AD values, and higher RD values, in corresponding anatomical areas in comparison to patients with normal electrophysiological findings at the compression level but also above at C3 (Figure 5 and Table S2).
Results of post hoc correlation analysis between quantitative electrophysiological parameters and dMRI metrics are shown in the Supplementary Results.
Relationship between dMRI and clinical mJOA scale at the C3 level in DCM
Exploratory correlation analysis revealed significant positive correlations between mJOA and f 1, FA, d and AD from the C3 level in lateral columns in DCM patients. FA, AD and d in the spinal lemniscus and FA in ventral columns showed significant positive correlations with the mJOA scale. A negative relationship was identified between the mJOA scale and RD in lateral columns (Figures 6 and S6).
FIGURE 6.

Correlations between dMRI metrics from C3 above the compression level and the modified Japanese Orthopaedic Association (mJOA) scale in DCM patients
DISCUSSION
Our study detected tract‐specific distinctions in diffusion metrics between NMDC and symptomatic DCM patients compared to HC in the GM and dorsal columns, that is, fasciculus gracilis, fasciculus cuneatus, and in the lateral columns composed of lateral corticospinal tracts and spinal lemniscus. DCM patients also showed additional alterations in the ventral columns compared to HC. Diffusion changes were found in the C3‐6 area as well as above the compression level at C3, and were accompanied by reduced cord cross‐sectional area at the C3 level in both NMDC and DCM relative to HC. Importantly, diffusion metrics in the GM and motor and sensory tracts correlated with relevant electrophysiological abnormalities and clinical mJOA scale, implying the critical importance of tract‐specific measures for future longitudinal studies.
Differences in dMRI metrics in the C3‐6 area in NMDC patients compared to HC confirmed incipient CSC damage in the early stages of degenerative compression in the dorsal and lateral tracts. The findings align with post‐mortem histopathological studies, in which chronic CSC compression led to damage of the lateral pial plexus resulting in limited blood flow and axonal degeneration of lateral corticospinal tracts and dorsal areas [1]. Malperfusion through the compressed anterior spinal artery initially affects GM, lateral columns and the anterior part of the dorsal columns and can ultimately result in progressive demyelination [1, 27]. Indeed, lower f 1 and FA and higher diffusivity metrics in the lateral and dorsal tracts and GM observed in our study in NMDC and DCM patients compared to HC suggest ongoing demyelination [13]. Differences in f 1 in the lateral and dorsal tracts separated DCM from NMDC with more profound deficits found in DCM than NMDC patients. Thus, dMRI alterations corroborate post‐mortem studies, which reported lesions of the anterior GM horns, the lateral tracts and the anterior part of the dorsal tracts but showed no changes in the ventral columns in the early stages of degenerative compression [13, 33]. Additional f 1 and RD deficits occur in ventral columns as the compression progresses from NMDC to symptomatic DCM. Our findings thus align with histopathological samples when revealing alterations in diffusion metrics in ventral columns in DCM but not in NMDC. Direct comparison between NMDC and DCM groups showed profound changes in dorsal and lateral columns as well as GM that further confirmed the influence of gradual alteration of arterial flow on the compression‐related deficits and myelopathy [34, 35]. Whilst lower FA corroborates previous DTI studies in DCM patients [10, 14, 36, 37, 38], asymptomatic patients with CSC compression [16] and patients with slowly progressing CSC compression [39], to date no study showed tract‐specific changes in a large sample of both NMDC and DCM patients. Spatial distinctions in alterations between DCM and NMDC further emphasize the necessity of tract‐specific analysis in CSC studies.
Our findings also demonstrate malicious effects of the compression on microstructural CSC integrity above the compression level at the C3 level. Deficits at C3 in NMDC were limited to the spinal lemniscus and were depicted solely using the ball‐and‐sticks f 1 metric pointing to incipient remote degeneration in NMDC patients in the early stages of degenerative CSC compression. As the compression progressed to DCM, additional f 1, FA and RD alterations in dorsal and lateral columns occurred. The ball‐and‐sticks f 1 demonstrated higher discrimination when showing changes in the spinal lemniscus that were not detected using the DTI model. Significantly lower f 1 and FA above the compression level in DCM patients compared to HC point to progressive anterograde and retrograde axonal degeneration of dorsal sensory pathways such as fasciculus gracilis, cuneatus and spinal lemniscus as well as lateral motor corticospinal tracts, respectively [1, 13, 14]. Alterations of FA at the C3 level are in agreement with a recent study from Seif et al. [14] which demonstrated a remote FA decrease in the lateral corticospinal and spinothalamic tracts at the C2/3 level in DCM patients and patients with traumatic spinal cord injury compared to HC. Changes in GM along with spinal cord CSA reduction above the compression level in DCM patients compared to NMDC patients and HC point to trans‐synaptic degeneration and GM atrophy above the stenosis level in patients with myelopathy [13]. Direct comparison between symptomatic DCM and NMDC patients demonstrated more severe deficits in DCM patients in the dorsal and lateral columns, as well as in the ventral and dorsal GM horns. Whereas remote degeneration in DCM patients compared to HC corroborates previous reports [13, 14, 38, 40, 41], tract‐based approaches also delineated gradual changes between NMDC and symptomatic DCM patients. Alterations above the compression level further endorse brain studies [42, 43, 44] that reported changes in motor and somatosensory cortex in symptomatic DCM patients with degenerative CSC compression. A decrease of CSA at the C3 level in DCM compared to HC corresponds with previous studies [10, 13, 14, 40] and further points to remote degeneration rostrally to MCL. A smaller yet significant CSA deficit was also found in the NMDC group, suggesting more profound changes in DCM than in NMDC compared to HC.
Tract‐specific analysis also revealed a relationship between the degree of disability (i.e., mJOA scale) and diffusion metrics in lateral columns and spinal lemniscus comprising motor and sensory pathways in DCM patients. DCM patients with lower mJOA scale (worse DCM disability) exhibited a decrease of f 1, FA and AD and an increase of RD compared to NMDC patients and HC. These findings correspond to more severe demyelination and axonal damage in DCM patients with profound motor and sensory disability.
Most importantly, significant dMRI changes in individual tracts between patients with and without electrophysiological deficits point to a crucial relationship between functional impairments and microstructural dMRI degeneration. Patients with abnormal electrophysiology findings showed lower values of f 1, FA, d and AD metrics and higher values of RD and MD compared to those with normal electrophysiological findings. Microstructural changes in sensory and motor tracts were related to SEP and MEP, respectively, with altered GM found in patients with EMG changes. Whilst previous studies also examined the relationship between dMRI and electrophysiology, they failed to detect dMRI distinctions between patients with and without electrophysiological deficits [18], or detected FA alterations in DCM patients with normal SEP [38]. Whereas electrophysiological measures serve as essential predictors of DCM development [2, 6], optimized spatially selective tract‐based measures of the CSC overcome previous unselective dMRI analyses of the whole axial spinal cord volumes. Thus, the proven significant relationship between electrophysiology and tract‐based dMRI metrics suggest that tract‐specific analysis might provide an objective tool to examine the relationship between diffusion‐informed microstructural changes and functional electrophysiological impairments. Tract‐specific dMRI should be explored as a potential predictor in future longitudinal studies utilizing current high‐resolution methods. Also, dMRI is a non‐invasive tool that is easier to perform than electrophysiological measures.
Our outcomes imply the importance of novel dMRI models in CSC analysis. The multi‐compartment ball‐and‐sticks model, which incorporates intra‐axonal restriction and better explains the data than DTI [20], has not been utilized in a large sample of NMDC or DCM patients yet. The ball‐and‐sticks f 1 metric indeed revealed additional between‐group alterations at the C3‐6 area in GM as well as ventral columns and fasciculus cuneatus, which were not revealed by FA. Lemniscal alterations between NMDC patients and HCs at C3 above the compression level were also exclusively revealed by the ball‐and‐sticks f 1 metric.
Our study was limited by spatial coverage of dMRI data (i.e., the C3‐6 area). Caudal vertebral levels were not explored due to scanning time constraints and possible signal loss at the C7 level caused by the character of the HARDI‐ZOOMit protocol [21]. Semi‐automatic analyses also required time‐consuming manual adjustment of segmentations, mainly in patients with severe CSC compression. Severe compression further limited proper white matter atlas registration in five DCM patients. Although the atlas‐based approach provides higher accuracy and less propensity to susceptibility distortions than tractography‐based methods [45], future studies may benefit from subject‐specific tractography approaches, which are not yet fully developed.
In conclusion, the combination of conventional DTI and the multi‐compartment ball‐and‐sticks model allowed to reveal tract‐specific dMRI changes congruent with previous histopathological studies. Compression‐caused demyelination, atrophy and axonal degeneration in white matter tracts and GM progressed from less severe NMDC to symptomatic DCM. Tract‐specific diffusion abnormalities correlated with clinical deficits and abnormal electrophysiology in relevant anatomical tracts. Thus, our study demonstrated that high‐resolution tract‐specific dMRI is a sensitive microstructural marker of CSC alterations for longitudinal trials aiming to provide early predictors of progression into symptomatic myelopathy and potentially can be translated also for patients with traumatic spinal cord injury.
CONFLICT OF INTEREST
No authors disclosed any relevant relationships.
AUTHOR CONTRIBUTIONS
Jan Valošek: Conceptualization (equal); data curation (equal); formal analysis (equal); funding acquisition (supporting); investigation (equal); methodology (equal); resources (supporting); software (equal); validation (equal); visualization (lead); writing—original draft (lead); writing—review and editing (lead). René Labounek: Conceptualization (equal); data curation (equal); formal analysis (equal); funding acquisition (equal); investigation (equal); methodology (equal); resources (equal); software (equal); supervision (equal); validation (equal); visualization (equal); writing—original draft (equal); writing—review and editing (equal). Tomáš Horák: Data curation (equal); formal analysis (equal); investigation (equal); methodology (equal); software (equal); validation (equal); visualization (equal); writing—original draft (equal); writing—review and editing (equal). Magda Horakova: Data curation (equal); investigation (equal); methodology (equal); project administration (equal); software (equal); validation (equal); visualization (equal); writing—original draft (equal); writing—review and editing (equal). Petr Bednařík: Conceptualization (equal); data curation (equal); formal analysis (equal); funding acquisition (equal); investigation (equal); methodology (equal); resources (equal); software (equal); supervision (equal); validation (equal); visualization (equal); writing—original draft (equal); writing—review and editing (equal). Miloš Keřkovský: Conceptualization (equal); data curation (equal); formal analysis (equal); funding acquisition (equal); investigation (equal); methodology (equal); project administration (equal); resources (equal); software (equal); supervision (equal); validation (equal); writing—original draft (equal); writing—review and editing (equal). Jan Kočica: Data curation (equal); investigation (equal); validation (equal); visualization (equal); writing—original draft (equal); writing—review and editing (equal). Tomáš Rohan: Data curation (equal); investigation (equal); validation (equal); visualization (equal); writing—original draft (equal); writing—review and editing (equal). Christophe Lenglet: Conceptualization (equal); investigation (equal); methodology (equal); supervision (equal); visualization (equal); writing—original draft (equal); writing—review and editing (equal). Julien Cohen‐Adad: Data curation (equal); investigation (equal); methodology (equal); supervision (equal); validation (equal); visualization (equal); writing—original draft (equal); writing—review and editing (equal). Petr Hlustik: Conceptualization (equal); data curation (equal); formal analysis (equal); funding acquisition (equal); investigation (equal); methodology (equal); project administration (equal); resources (equal); software (equal); supervision (lead); validation (equal); visualization (equal); writing—original draft (equal); writing—review and editing (equal). Eva Vlckova: Conceptualization (equal); data curation (equal); formal analysis (equal); funding acquisition (equal); investigation (equal); methodology (equal); project administration (equal); validation (equal); visualization (equal); writing—original draft (equal); writing—review and editing (equal). Zdeněk Kadaňka Jr: Conceptualization (equal); investigation (equal); methodology (equal); validation (equal); visualization (equal); writing—original draft (equal); writing—review and editing (equal). Josef Bednarik: Conceptualization (lead); data curation (equal); formal analysis (equal); funding acquisition (lead); investigation (equal); methodology (equal); project administration (lead); resources (lead); software (equal); supervision (lead); validation (equal); visualization (equal); writing—original draft (equal); writing—review and editing (equal). Alena Svatkova: Conceptualization (equal); data curation (equal); formal analysis (equal); funding acquisition (equal); investigation (equal); methodology (equal); resources (equal); software (equal); supervision (lead); validation (equal); visualization (equal); writing—original draft (equal); writing—review and editing (equal).
Supporting information
Supplementary Material
ACKNOWLEDGEMENTS
The authors would like to thank to Pavel Hok for help with data processing, Petr Kudlička and Veronika Fábíková for MRI data acquisition and Dagmar Kratochvílová for subject recruitment.
Valošek J, Labounek R, Horák T, et al. Diffusion magnetic resonance imaging reveals tract‐specific microstructural correlates of electrophysiological impairments in non‐myelopathic and myelopathic spinal cord compression. Eur J Neurol. 2021;28:3784–3797. 10.1111/ene.15027
Funding information
The core facility Multimodal and Functional Imaging Laboratory, Masaryk University, CEITEC, supported by the MEYS CR (LM2018129 Czech‐BioImaging) is acknowledged. This research is funded by the Czech Health Research Council grants NV18‐04‐00159 and by the Ministry of Health of the Czech Republic project for conceptual development in research organizations, ref. 65269705 (University Hospital, Brno, Czech Republic). JV has received “Aktion Österreich‐Tschechien, AÖCZ‐Semesterstipendien” scholarship MPC‐2020‐00013 from Austrian Agency for International Cooperation in Education and Research (OeAD‐GmbH), Mobility Programmes, Bilateral and Multilateral Cooperation (MPC) financed by Federal Ministry of Education, Science and Research (BMBWF) of Austria. AS has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska‐Curie grant agreement no. 794986. PB was partially supported by a NARSAD Young Investigator Grant from the Brain and Behavior Research Foundation (grant no. 27238) and by the European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska‐Curie grant agreement no. 846793. CL is partly supported by NIH grants P41 EB027061 and P30 NS076408. Computational resources were supplied by the project “e‐Infrastruktura CZ” (e‐INFRA LM2018140) provided within the program Projects of Large Research, Development and Innovations Infrastructures. JCA is funded by the Canada Research Chair in Quantitative Magnetic Resonance Imaging (950‐230815), the Canadian Institute of Health Research (CIHR FDN‐143263), the Canada Foundation for Innovation (32454, 34824), the Fonds de Recherche du Québec—Santé (28826), the Natural Sciences and Engineering Research Council of Canada (RGPIN‐2019‐07244), the Canada First Research Excellence Fund (IVADO and TransMedTech), the Courtois NeuroMod project and the Quebec BioImaging Network (5886, 35450).
DATA AVAILABILITY STATEMENT
The data that support the findings of this study are available from the corresponding author upon reasonable request.
REFERENCES
- 1. Badhiwala JH, Ahuja CS, Akbar MA, et al. Degenerative cervical myelopathy—update and future directions. Nat Rev Neurol. 2020;16:108‐124. [DOI] [PubMed] [Google Scholar]
- 2. Bednarik J, Kadanka Z, Dusek L, et al. Presymptomatic spondylotic cervical myelopathy: an updated predictive model. Eur Spine J. 2008;17:421‐431. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Smith SS, Stewart ME, Davies BM, et al. The prevalence of asymptomatic and symptomatic spinal cord compression on magnetic resonance imaging: a systematic review and meta‐analysis. Global Spine Journal. 2021;11(4):597‐607. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Kovalova I, Kerkovsky M, Kadanka Z, et al. Prevalence and imaging characteristics of nonmyelopathic and myelopathic spondylotic cervical cord compression. Spine (Phila Pa 1976). 2016;41(24):1908‐1916. [DOI] [PubMed] [Google Scholar]
- 5. Adamova B, Bednarik J, Andrasinova T, et al. Does lumbar spinal stenosis increase the risk of spondylotic cervical spinal cord compression? Eur Spine J. 2015;24:2946‐2953. [DOI] [PubMed] [Google Scholar]
- 6. Kadanka Z, Adamova B, Kerkovsky M, et al. Predictors of symptomatic myelopathy in degenerative cervical spinal cord compression. Brain Behav. 2017;7:e00797. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Bednarik J, Kadanka Z, Dusek L, et al. Presymptomatic spondylotic cervical cord compression. Spine (Phila Pa 1976). 2004;29(20):2260‐2269. [DOI] [PubMed] [Google Scholar]
- 8. Witiw CD, Mathieu F, Nouri A, et al. Clinico‐radiographic discordance: an evidence‐based commentary on the management of degenerative cervical spinal cord compression in the absence of symptoms or with only mild symptoms of myelopathy. Glob Spine J. 2018;8:527‐534. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Wilson JR, Barry S, Fischer DJ, et al. Frequency, timing, and predictors of neurological dysfunction in the nonmyelopathic patient with cervical spinal cord compression, canal stenosis, and/or ossification of the posterior longitudinal ligament. Spine (Phila Pa 1976). 2013;38:S37‐S54. [DOI] [PubMed] [Google Scholar]
- 10. Martin AR, De Leener B, Cohen‐Adad J, et al. A novel MRI biomarker of spinal cord white matter injury: T2*‐weighted white matter to gray matter signal intensity ratio. Am J Neuroradiol. 2017;38:1266‐1273. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Dong F, Wu Y, Song P, et al. A preliminary study of 3.0‐T magnetic resonance diffusion tensor imaging in cervical spondylotic myelopathy. Eur Spine J. 2018;27:1839‐1845. [DOI] [PubMed] [Google Scholar]
- 12. Shabani S, Kaushal M, Budde MD, et al. Diffusion tensor imaging in cervical spondylotic myelopathy: a review. J Neurosurg Spine. 2020;33:65‐72. [DOI] [PubMed] [Google Scholar]
- 13. David G, Mohammadi S, Martin AR, et al. Traumatic and nontraumatic spinal cord injury: pathological insights from neuroimaging. Nat Rev Neurol. 2019;15:718‐731. [DOI] [PubMed] [Google Scholar]
- 14. Seif M, David G, Huber E, et al. Cervical cord neurodegeneration in traumatic and non‐traumatic spinal cord injury. J Neurotrauma. 2020;37:860‐867. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Martin AR, De Leener B, Cohen‐Adad J, et al. Monitoring for myelopathic progression with multiparametric quantitative MRI. PLoS One. 2018;13(4):e0195733. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Martin AR, De Leener B, Cohen‐Adad J, et al. Can microstructural MRI detect subclinical tissue injury in subjects with asymptomatic cervical spinal cord compression? A prospective cohort study. BMJ Open. 2018;8:e019809. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Keřkovský M, Bednařík J, Jurová B, et al. Spinal cord MR diffusion properties in patients with degenerative cervical cord compression. J Neuroimaging. 2017;27:149‐157. [DOI] [PubMed] [Google Scholar]
- 18. Kerkovský M, Bednarík J, Dušek L, et al. Magnetic resonance diffusion tensor imaging in patients with cervical spondylotic spinal cord compression: correlations between clinical and electrophysiological findings. Spine (Phila Pa 1976). 2012;37(1):48‐56. [DOI] [PubMed] [Google Scholar]
- 19. Basser PJ, Mattiello J, LeBihan D. MR diffusion tensor spectroscopy and imaging. Biophys J. 1994;66:259‐267. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Panagiotaki E, Schneider T, Siow B, et al. Compartment models of the diffusion MR signal in brain white matter: a taxonomy and comparison. NeuroImage. 2012;59:2241‐2254. [DOI] [PubMed] [Google Scholar]
- 21. Labounek R, Valošek J, Horák T, et al. HARDI‐ZOOMit protocol improves specificity to microstructural changes in presymptomatic myelopathy. Sci Rep. 2020;10:17529. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Behrens TEJ, Woolrich MW, Jenkinson M, et al. Characterization and propagation of uncertainty in diffusion‐weighted MR imaging. Magn Reson Med. 2003;50:1077‐1088. [DOI] [PubMed] [Google Scholar]
- 23. Gros C, De Leener B, Badji A, et al. Automatic segmentation of the spinal cord and intramedullary multiple sclerosis lesions with convolutional neural networks. NeuroImage. 2019;184:901‐915. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. De Leener B, Fonov VS, Collins DL, Callot V, Stikov N, Cohen‐Adad J. PAM50: unbiased multimodal template of the brainstem and spinal cord aligned with the ICBM152 space. NeuroImage. 2018;165:170‐179. [DOI] [PubMed] [Google Scholar]
- 25. Lévy S, Benhamou M, Naaman C, et al. White matter atlas of the human spinal cord with estimation of partial volume effect. NeuroImage. 2015;119:262‐271. [DOI] [PubMed] [Google Scholar]
- 26. De Leener B, Lévy S, Dupont SM, et al. SCT: Spinal Cord Toolbox, an open‐source software for processing spinal cord MRI data. NeuroImage. 2017;145:24‐43. [DOI] [PubMed] [Google Scholar]
- 27. Mair WGP, Druckman R. The pathology of spinal cord lesions and their relation to the clinical features in protrusion of cervical intervertebral discs (a report of four cases). Brain. 1953;76:70‐91. [DOI] [PubMed] [Google Scholar]
- 28. Tetreault L, Kopjar B, Nouri A, et al. The modified Japanese Orthopaedic Association scale: establishing criteria for mild, moderate and severe impairment in patients with degenerative cervical myelopathy. Eur Spine J. 2017;26:78‐84. [DOI] [PubMed] [Google Scholar]
- 29. Bednařík J, Kadaňka Z, Voháňka S, et al. The value of somatosensory and motor evoked potentials in pre‐clinical spondylotic cervical cord compression. Eur Spine J. 1998;7:493‐500. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Caruyer E, Lenglet C, Sapiro G, et al. Design of multishell sampling schemes with uniform coverage in diffusion MRI. Magn Reson Med. 2013;69:1534‐1540. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Jenkinson M, Beckmann CF, Behrens TEJ, et al. FSL. NeuroImage. 2012;62:782‐790. [DOI] [PubMed] [Google Scholar]
- 32. Ullmann E, Pelletier Paquette JF, Thong WE, et al. Automatic labeling of vertebral levels using a robust template‐based approach. Int J Biomed Imaging. 2014;2014:719520. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Cohen‐Adad J. Microstructural imaging in the spinal cord and validation strategies. NeuroImage. 2018;182:169‐183. [DOI] [PubMed] [Google Scholar]
- 34. Badhiwala JH, Ahuja CS, Akbar MA, et al. Degenerative cervical myelopathy ‐ update and future directions. Nat Rev Neurol. 2020;16(2):108‐124. [DOI] [PubMed] [Google Scholar]
- 35. Baptiste DC, Fehlings MG. Pathophysiology of cervical myelopathy. Spine J. 2006;6(6 Suppl):190S‐197S. [DOI] [PubMed] [Google Scholar]
- 36. Lee JW, Kim JH, Park JB, et al. Diffusion tensor imaging and fiber tractography in cervical compressive myelopathy: preliminary results. Skeletal Radiol. 2011;40:1543‐1551. [DOI] [PubMed] [Google Scholar]
- 37. Lindberg PG, Sanchez K, Ozcan F, et al. Correlation of force control with regional spinal DTI in patients with cervical spondylosis without signs of spinal cord injury on conventional MRI. Eur Radiol. 2016;26:733‐742. [DOI] [PubMed] [Google Scholar]
- 38. Wen CY, Cui JL, Liu HS, et al. Is diffusion anisotropy a biomarker for disease severity and surgical prognosis of cervical spondylotic myelopathy. Radiology. 2014;270:197‐204. [DOI] [PubMed] [Google Scholar]
- 39. Facon D, Ozanne A, Fillard P, et al. MR diffusion tensor imaging and fiber tracking in spinal cord compression. AJNR Am J Neuroradiol. 2005;26:1587‐1594. [PMC free article] [PubMed] [Google Scholar]
- 40. Grabher P, Mohammadi S, Trachsler A, et al. Voxel‐based analysis of grey and white matter degeneration in cervical spondylotic myelopathy. Sci Rep. 2016;6:24636. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Budzik J‐F, Balbi V, Le Thuc V, Duhamel A, Assaker R, Cotten A. Diffusion tensor imaging and fibre tracking in cervical spondylotic myelopathy. Eur Radiol. 2011;21:426‐433. [DOI] [PubMed] [Google Scholar]
- 42. Kowalczyk I, Duggal N, Bartha R. Proton magnetic resonance spectroscopy of the motor cortex in cervical myelopathy. Brain. 2012;135:461‐468. [DOI] [PubMed] [Google Scholar]
- 43. Bernabéu‐Sanz Á, Mollá‐Torró JV, López‐Celada S, et al. MRI evidence of brain atrophy, white matter damage, and functional adaptive changes in patients with cervical spondylosis and prolonged spinal cord compression. Eur Radiol. 2020;30:357‐369. [DOI] [PubMed] [Google Scholar]
- 44. Zhou FQ, Tan YM, Wu L, Zhuang Y, He LC, Gong HH. Intrinsic functional plasticity of the sensory‐motor network in patients with cervical spondylotic myelopathy. Sci Rep. 2015;5(1):9975. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Cohen‐Adad J, Wheeler‐Kingshott C. Quantitative MRI of the Spinal Cord. San Diego, CA: Academic Press (Elsevier); 2014. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Supplementary Material
Data Availability Statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.
